Old Web
English
Sign In
Acemap
>
Paper
>
A-75 Effects of Rivastigmine on Neurocognitive Deficits in Patients with Parkinson’s Disease
A-75 Effects of Rivastigmine on Neurocognitive Deficits in Patients with Parkinson’s Disease
2021
C Roper
Rainer von Coelln
Lisa M. Shulman
Kristen Mordecai
Keywords:
in patient
Movement disorders
Physical medicine and rehabilitation
Neurocognitive
Visuospatial ability
Dementia
Rivastigmine
Montreal Cognitive Assessment
Parkinson's disease
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]